Mesa Laboratories Revenue 2010-2024 | MLAB
Mesa Laboratories revenue from 2010 to 2024. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sales of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
| Mesa Laboratories Annual Revenue (Millions of US $) |
|
|---|---|
| 2024 | $216 |
| 2023 | $219 |
| 2022 | $184 |
| 2021 | $134 |
| 2020 | $118 |
| 2019 | $103 |
| 2018 | $96 |
| 2017 | $94 |
| 2016 | $85 |
| 2015 | $71 |
| 2014 | $53 |
| 2013 | $46 |
| 2012 | $40 |
| 2011 | $34 |
| 2010 | $22 |
| 2009 | $22 |
| Mesa Laboratories Quarterly Revenue (Millions of US $) |
|
|---|---|
| 2024-06-30 | $58 |
| 2024-03-31 | $59 |
| 2023-12-31 | $53 |
| 2023-09-30 | $53 |
| 2023-06-30 | $51 |
| 2023-03-31 | $56 |
| 2022-12-31 | $54 |
| 2022-09-30 | $59 |
| 2022-06-30 | $50 |
| 2022-03-31 | $59 |
| 2021-12-31 | $55 |
| 2021-09-30 | $36 |
| 2021-06-30 | $35 |
| 2021-03-31 | $38 |
| 2020-12-31 | $34 |
| 2020-09-30 | $32 |
| 2020-06-30 | $30 |
| 2020-03-31 | $34 |
| 2019-12-31 | $32 |
| 2019-09-30 | $26 |
| 2019-06-30 | $26 |
| 2019-03-31 | $26 |
| 2018-12-31 | $27 |
| 2018-09-30 | $25 |
| 2018-06-30 | $25 |
| 2018-03-31 | $27 |
| 2017-12-31 | $24 |
| 2017-09-30 | $23 |
| 2017-06-30 | $23 |
| 2017-03-31 | $24 |
| 2016-12-31 | $24 |
| 2016-09-30 | $24 |
| 2016-06-30 | $21 |
| 2016-03-31 | $25 |
| 2015-12-31 | $20 |
| 2015-09-30 | $22 |
| 2015-06-30 | $18 |
| 2015-03-31 | $19 |
| 2014-12-31 | $18 |
| 2014-09-30 | $19 |
| 2014-06-30 | $16 |
| 2014-03-31 | $16 |
| 2013-12-31 | $13 |
| 2013-09-30 | $13 |
| 2013-06-30 | $11 |
| 2013-03-31 | $13 |
| 2012-12-31 | $11 |
| 2012-09-30 | $12 |
| 2012-06-30 | $11 |
| 2012-03-31 | $11 |
| 2011-12-31 | $10 |
| 2011-09-30 | $10 |
| 2011-06-30 | $9 |
| 2011-03-31 | $11 |
| 2010-12-31 | $8 |
| 2010-09-30 | $8 |
| 2010-06-30 | $7 |
| 2010-03-31 | $6 |
| 2009-12-31 | $5 |
| 2009-09-30 | $5 |
| 2009-06-30 | $5 |
| 2009-03-31 | $5 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $0.678B | $0.216B |
| MESA LABORATORIES, INC. designs, develops, acquires, manufactures and markets instruments and systems utilized in connection with industrial applications and hemodialysis therapy. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $227.459B | 27.26 |
| Intuitive Surgical (ISRG) | United States | $170.849B | 96.74 |
| Alcon (ALC) | Switzerland | $47.307B | 33.30 |
| IQVIA Holdings (IQV) | United States | $41.331B | 23.42 |
| Edwards Lifesciences (EW) | United States | $41.289B | 26.46 |
| IDEXX Laboratories (IDXX) | United States | $39.139B | 47.08 |
| DexCom (DXCM) | United States | $27.822B | 39.67 |
| STERIS (STE) | Ireland | $22.408B | 26.15 |
| SONOVA HOLDING (SONVY) | Switzerland | $22.087B | 0.00 |
| Waters (WAT) | United States | $21.306B | 31.76 |
| Hologic (HOLX) | United States | $18.642B | 20.27 |
| Sysmex ADR (SSMXY) | Japan | $12.413B | 38.93 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $11.737B | 13.16 |
| Teleflex (TFX) | United States | $11.070B | 17.21 |
| Globus Medical (GMED) | United States | $9.487B | 26.54 |
| Penumbra (PEN) | United States | $7.567B | 78.55 |
| Masimo (MASI) | United States | $7.444B | 39.87 |
| Glaukos (GKOS) | United States | $7.103B | 0.00 |
| TransMedics (TMDX) | United States | $4.608B | 197.31 |
| Integer Holdings (ITGR) | United States | $4.333B | 25.34 |
| PROCEPT BioRobotics (PRCT) | United States | $3.843B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.826B | 16.58 |
| Elekta AB (EKTAY) | Sweden | $2.626B | 21.39 |
| Tandem Diabetes Care (TNDM) | United States | $2.610B | 0.00 |
| Veracyte (VCYT) | United States | $2.572B | 159.43 |
| Inari Medical (NARI) | United States | $2.471B | 0.00 |
| Nihon Kohden (NHNKY) | Japan | $2.325B | 14.47 |
| RxSight (RXST) | United States | $1.822B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $1.357B | 6.18 |
| Artivion (AORT) | United States | $1.077B | 98.85 |
| AVANOS MEDICAL, INC (AVNS) | United States | $1.029B | 18.35 |
| OPKO Health (OPK) | United States | $1.025B | 0.00 |
| Pulse Biosciences (PLSE) | United States | $0.968B | 0.00 |
| Alphatec Holdings (ATEC) | United States | $0.756B | 0.00 |
| IRadimed (IRMD) | United States | $0.625B | 33.77 |
| AxoGen (AXGN) | United States | $0.597B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.593B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.576B | 0.00 |
| SiBone (SIBN) | United States | $0.561B | 0.00 |
| Pacific Biosciences Of California (PACB) | United States | $0.461B | 0.00 |
| Paragon 28 (FNA) | United States | $0.439B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.336B | 10.23 |
| Treace Medical Concepts (TMCI) | United States | $0.322B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.321B | 0.00 |
| Sight Sciences (SGHT) | United States | $0.282B | 0.00 |
| AngioDynamics (ANGO) | United States | $0.239B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.235B | 0.00 |
| Inogen (INGN) | United States | $0.218B | 0.00 |
| NeuroPace (NPCE) | United States | $0.187B | 0.00 |
| Accuray (ARAY) | United States | $0.185B | 0.00 |
| CVRx (CVRX) | United States | $0.183B | 0.00 |
| Semler Scientific (SMLR) | United States | $0.179B | 12.56 |
| Atossa Genetics (ATOS) | United States | $0.179B | 0.00 |
| Nevro (NVRO) | United States | $0.175B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.160B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.125B | 0.00 |
| 908 Devices (MASS) | United States | $0.121B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.111B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.106B | 15.78 |
| EDAP TMS S.A (EDAP) | France | $0.099B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.078B | 0.00 |
| Monogram Orthopaedics (MGRM) | United States | $0.074B | 0.00 |
| Hyperfine (HYPR) | United States | $0.073B | 0.00 |
| InspireMD (NSPR) | Israel | $0.067B | 0.00 |
| Covalon Technologies (CVALF) | Canada | $0.063B | 0.00 |
| Envoy Medical (COCH) | United States | $0.057B | 0.00 |
| LENSAR (LNSR) | United States | $0.054B | 0.00 |
| Accelerate Diagnostics (AXDX) | United States | $0.045B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.043B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.041B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.039B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.035B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.035B | 0.00 |
| DarioHealth (DRIO) | United States | $0.032B | 0.00 |
| Precision Optics (POCI) | United States | $0.029B | 0.00 |
| T2 Biosystems (TTOO) | United States | $0.027B | 0.00 |
| Neuronetics (STIM) | United States | $0.026B | 0.00 |
| Pixie Dust Technologies (PXDT) | Japan | $0.024B | 0.00 |
| Spectral AI (MDAI) | United States | $0.019B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.019B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.017B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.017B | 0.00 |
| NexGel (NXGL) | United States | $0.015B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.014B | 0.00 |
| Aspira Women's Health (AWH) | United States | $0.013B | 0.00 |
| QT Imaging Holdings (QTI) | United States | $0.013B | 0.00 |
| PAVmed (PAVM) | United States | $0.012B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.008B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| ReShape Lifesciences (RSLS) | United States | $0.003B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.002B | 0.00 |
| Nuwellis (NUWE) | United States | $0.002B | 0.00 |
| Avinger (AVGR) | United States | $0.002B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.002B | 0.00 |
| Tenon Medical (TNON) | United States | $0.002B | 0.00 |
| Helius Medical Technologies (HSDT) | United States | $0.002B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.002B | 0.00 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |